fem-dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1® and RC-14® to colonize and protect the vaginal tract.*

Clinical trials have shown that GR-1® and RC-14®:

• Help to maintain or restore healthy vaginal flora that are important in maintaining vaginal health*
• Support the health of the urinary tract*

fem-dophilus® is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus® are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.*

Ingredients: Total Probiotic Bacteria 5 billion cfu (Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC-14).

Other Ingredients: Dextrose anhydrate, potato starch, microcrystalline cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.

Contains: Dairy (casein, in trace amounts).

No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.